Relapsed or Refractory B-cell Hematologic Malignancies
2 clinical trials · Condition
◉ Watch Relapsed or Refractory B-cell Hematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies (NCT04865458) | Sunshine Lake Pharma Co., Ltd. | 2021-04-01 |
Track Relapsed or Refractory B-cell Hematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.